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Abstract
Background: The aim of this prospective study is to evaluate the role in the onset of surgical site
infections of bilateral internal thoracic arteries harvesting in patients with decompensated
preoperative glycemia.
Methods: 81 consecutive patients with uncontrolled diabetes mellitus underwent elective CABG
harvesting single or double internal thoracic arteries. Single left ITA was harvested in 41 patients
(Group 1, 50.6%), BITAs were harvested in 40 (Group 2, 49.4%). The major clinical end points
analyzed in this study were infection rate, type of infection, duration of infection, infection relapse
rate and total hospital length of stay.
Results: Five patients developed sternal SSI in the perioperative period, 2 in group 1 and 3 in group
2 without significant difference. All sternal SSIs were superficial with no sternal dehiscence. The
development of infection from the time of surgery took 18.5 ± 2.1 and 7.3 ± 3.0 days for Groups
1 and 2 respectively. The infections were treated with wound irrigation and debridement, and with
VAC therapy as well as with antibiotics. The VAC system was removed after a mean of 12.8 ± 5.1
days, when sterilization was achieved. The overall survival estimate at 1 year was 98.7%. Only BMI
was a significant predictor of SSI using multivariate stepwise logistic regression analysis (Odds Ratio:
1.34; 95%Conficdence Interval: 1.02–1.83; p value: 0.04). In the model, the use of BITA was not an
independent predictor of SSI.
Conclusion:  CABG with bilateral pedicled ITAs grafting could be performed safely even in
diabetics with poor preoperative glycaemic control.
Published: 23 June 2008
Journal of Cardiothoracic Surgery 2008, 3:35 doi:10.1186/1749-8090-3-35
Received: 6 February 2008
Accepted: 23 June 2008
This article is available from: http://www.cardiothoracicsurgery.org/content/3/1/35
© 2008 Agrifoglio et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Cardiothoracic Surgery 2008, 3:35 http://www.cardiothoracicsurgery.org/content/3/1/35
Page 2 of 6
(page number not for citation purposes)
Background
The role of diabetes in the onset of surgical site infections
(SSI) is well established, especially in patients with
uncontrolled-glycaemia levels[1]. It represents a predis-
posing factor, as it leads to microvascular alterations and
decreased wound healing [2,3]. Moreover, it interferes
with the immunological response against infection. The
diabetic pattern synergically increases the impact of other
risk factors, such as obesity, gender, age, tobacco use, res-
piratory disease, or local impairment of vascularization
[1,4].
The harvesting of internal thoracic artery (ITA) for coro-
nary artery bypass grafting (CABG) leads to an acute
decrease of the sternal circulation [5]. It was demonstrated
to reduce significantly the perfusion of the hemi-sternum
in the perioperative period, while after few weeks, collat-
eral circulation can supply it [5-7]. Hence, the sternal
wound is exposed to increased risk of dehiscence and SSI
by its nature, especially when other risk factors are
present.
Starting from this issue, the harvesting of bilateral internal
thoracic arteries (BITAs) has been considered an adjunc-
tive risk factor for postoperative sternal wound complica-
tion [8] and consequently it has been contraindicated in
diabetic patients at high risk. If the use of BITAs in diabet-
ics is associated with a higher rate of morbidity and mor-
tality, one could question the wisdom of using bilateral
ITA grafting for a potential long-term benefit that would
be neutralized by an increased early risk [9-12]. The aim
of this prospective non-randomized study was to evaluate
the role of BITAs versus single ITA grafting in a population
of diabetic patients with decompensated preoperative gly-
cemia undergoing on-pump CABG with no associated
procedures.
Methods
From January 2006 and July 2006, 81 consecutive patients
with uncontrolled diabetes mellitus underwent elective
CABG harvesting single or double internal thoracic arter-
ies (27.5% of all CABGs in the same period).
Single left ITA was harvested in 41 patients (Group 1,
50.6%), BITAs were harvested in 40 (Group 2, 49.4%).
The choice of single or double ITAs was guided by
patient's age, clinical status and surgeon's preference. In
all cases, ITAs were dissected non-skeletonized from the
thoracic wall, along with internal thoracic veins, muscles,
and fascia.
The two groups were compared with regards to their base-
line characteristics, operative factors, and clinical out-
comes. Baseline characteristics included age, gender,
primary cardiac pathology, presence of hypertension, dia-
betes, chronic obstructive pulmonary disease (COPD),
obesity, Body Mass Index (BMI), renal failure, peripheral
vascular disease, hypercholesterolemia, smoking history,
previous cardiac operations, previous myocardial infarc-
tion, the "European System for Cardiac Operative Risk
Evaluation" (EuroSCORE) [13-15]. The operative factors
examined were type of surgery, duration of operation, re-
exploration for bleeding, the amount of postoperative
bleeding, the number of transfused patients, the number
of transfusions, incidence of postoperative intubation,
and intra-aortic balloon pump (IABP) insertion during or
after surgery, intensive care unit (ICU) stay. No different
surgical techniques were used in the 2 groups and only the
number of drainage tubes differed. Patients in Group 2
received 2 adjunctive drainages, one placed in the anterior
mediastinum and one between sternum and pectoralis
fascia.
In perioperative period, the patients' blood glucose levels
were monitored and insulin treatment was administered,
if necessary, with the goal of keeping blood sugar levels at
or below the safe limit of 200 mg/100 ml [16].
The major clinical end points analyzed in this study were
infection rate, type of infection, duration of infection,
infection relapse rate, rate of hospital readmission, dura-
tion of antibiotic use, and total hospital length of stay.
The presence of sternal SSIs was determined using the
Center of Disease Control (CDC) criteria [17]. Manage-
ment of organ/space sternal SSIs in all patients started
with an initial empirical antimicrobial therapy. The subse-
quent therapy was dynamically guided by the antibiotic
susceptibility tests. Antibiotic therapy was managed by an
infectious disease physician, together with the cardiac
team. The treatment of organ/space sternal SSIs was previ-
ously described [18]. Superficial sternal SSIs was per-
formed in the same fashion through reopening of the
surgical suture, debridement of all infected and avascular
tissue, curettage of the cutaneous/subcutaneous tissues
and daily local debridement with antiseptic irrigation
until the site sterility was reached. Vacuum-assisted
wound closure (VAC, KCl Inc., San Antonio, TX) therapy
was applied in all sternal SSI. VAC therapy is a non-inva-
sive active therapy, based on the application of negative
pressure by controlled suction to the wound surface
[19,20]. It is known to enhance granulation and wound
contraction. No hyperbaric oxygen therapy was used in
this group. Antibiotics were discontinued when no clini-
cal signs or symptoms of infection persisted and when 2
cultures obtained from the wound were found to be neg-
ative. Infection relapse was diagnosed by isolation of
organisms from an aseptically obtained culture and clini-
cal data according to the Center of Disease Control (CDC)
criteria. The sternal wound was closed soon after steriliza-
tion.Journal of Cardiothoracic Surgery 2008, 3:35 http://www.cardiothoracicsurgery.org/content/3/1/35
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Data collection was prospective and preoperative, periop-
erative, and postoperative data were obtained from our
institutional database and reviewed using a standard data
collection form. Patients were regularly followed up at 3,
6, and 12 months. This study had the approval of our
institutional ethics committee, and written informed con-
sent was obtained from every patient by the senior inves-
tigator in accordance with institutional guidelines.
Statistical analysis
Categorical variables are represented as frequency distri-
butions and single percentages. Values of continuous var-
iables are expressed as a mean ± standard deviation (SD).
Continuous variables were compared using an independ-
ent t-test, and categorical variables were compared by χ2
and Fisher's exact test, where appropriate.
Significant predictors of sternal SSI were investigated by a
stepwise logistic regression analysis on preoperative, oper-
ative and postoperative factors.
Actuarial life table estimates were constructed using the
Kaplan-Meier method.
For all analyses, two-sided p < 0.05 was considered signif-
icant. Statistical analysis was performed using SPSS 13.0
software (SPSS, Chicago, IL, USA).
Results
Preoperative data are represented in Table 1. Group 2 had
a significant lower age, better EF and EUROSCORE. It had
been related to the indications for performing BITA har-
vesting, younger age and good preoperative clinical status
being an indication to BITA CABGs. There were no signif-
icant differences in gender, number of diseased vessels,
and comorbidities between groups. Medical treatment of
diabetes was achieved preoperatively with insulin in 14
patients from Group I versus 14 patients from Group II
and with oral hypoglycemic agents in 27 patients from
Group I versus 26 patients from Group II (p = 0.896). Pre-
operative blood fasting glucose and glycated hemoglobin
were similar in the two groups.
Table 1: Preoperative Clinical Characteristics
Group 1 Group 2 p-value
Number of Patients 41 (50.6%) 40 (49.4%)
Mean Age (Years) 66.5 ± 8.0 62.3 ± 7.2 0.016
Gender 0.963
Male 35 (85.4%) 34 (85.0%)
Female 6 (14.6%) 6 (15.0%)
Cardiac Pathology
Coronary Artery Disease 41 (100%) 40 (100%)
Other 0 (0%) 0 (0%)
Number of Diseased Vessels 2.8 ± 0.4 2.9 ± 0.3 0.089
Two-vessel disease 10 (24.4%) 4 (10.0%) 0.140
Three-vessel disease 31 (75.6%) 36 (90.0%)
Hypertension 33 (80.5%) 25 (62.5%) 0.088
Diabetes 41 (100.0%) 40 (100.0%) 1.000
Non-Insulin-Dependent 34 (82.9%) 34 (85.0%) 0.799
Insulin-Dependent 7 (17.1%) 6 (15.0%)
Preoperative fasting plasma glucose (mg/dL) 155.6 ± 53.7 148.5 ± 43.1 0.511
Glycated haemoglobin (%) 8.3 ± 0.9 8.6 ± 1.0 0.876
Body Mass Index 27.9 ± 4.1 26.9 ± 3.1 0.235
Body Surface Area (m2) 1.8 ± 0.1 1.8 ± 0.2 0.814
Chronic Obstructive Pulmonary Disease 6 (14.6%) 4 (10.0%) 0.737
Renal Failure 5 (12.1%) 3 (7.5%) 0.712
Serum creatinine (mg/dL) 1.1 ± 0.2 1.0 ± 0.2 0.471
Peripheral vascular disease 10 (24.4%) 5 (12.5%) 0.253
Previous stroke 1 (2.4%) 0 (0.0%) 1.000
C reactive protein (mg/dL) 4.1 ± 5.7 3.5 ± 6.8 0.653
Hypercholesterolemia 27 (65.9%) 27 (67.5%) 1.000
Smoking History 26 (63.4%) 26 (65.0%) 1.000
Previous Cardiac Surgery 0 (0.0%) 0 (0.0%)
Previous myocardial infarction 22 (53.7%) 11 (27.5%) 0.024
Ejection fraction 53.7 ± 11.4 58.2 ± 8.0 0.041
EuroScore 4.2 ± 2.7 2.3 ± 1.6 0.000
Length of Hospital Stay prior to Surgery (Days) 4.0 ± 3.0 3.6 ± 3.3 0.753
Inotropic Drugs before Surgery 2 (4.9%) 2 (5.0%) 1.000Journal of Cardiothoracic Surgery 2008, 3:35 http://www.cardiothoracicsurgery.org/content/3/1/35
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Operative data are shown in Table 2. All patients in this
study underwent on pump Coronary Artery Bypass Graft-
ing (CABG). No additional cardiac procedures were per-
formed in each case. The number of distal anastomoses
were comparable in both groups but distal anastomoses
with venous and arterial grafts were significantly higher in
group 1 and 2 respectively. Even the cross-clamping time,
the CPB time and the duration of operation were signifi-
cant higher in Group 2, reflecting the technical difficulties
related to the RITA grafting. Re-exploration for bleeding,
transfusions, ICU stay and postoperative intubation were
similar for both groups. IABP insertion during or after sur-
gery was needed in no cases. None of the patients in either
group had infections related to other organs or surgical
sites. Glycaemia was strictly monitored and controlled in
all patients, in the preoperative, perioperative and postop-
erative period.
5 patients developed sternal SSI in the perioperative
period, 2 in group 1 and 3 in group 2 without significant
difference (Table 3). All sternal SSIs were superficial with
no sternal dehiscence. The wound bacteriology was also
found comparable for both groups in order of Staphyloco-
ccus epidermidis and  Staphylococcus aureus. The develop-
ment of infection from the time of surgery took 18.5 ± 2.1
and 7.3 ± 3.0 days for Groups 1 and 2 respectively. No sta-
tistical analysis was performed considering the small
number of patients who developed SSI. As describe above,
the infections were treated with wound irrigation and
debridement, and with VAC therapy as well as with anti-
biotics. The VAC system was removed after a mean of 12.8
± 5.1 days, when sterilization was achieved.
At one-year follow-up, only 1 non-cardiac death occurred
in Group 1. The overall survival estimate at 1 year was
98.7%. No further sternal SSI, dehiscence, or infection
relapses occurred at 1 year follow-up.
All preoperative, operative and postoperative data were
included in the multivariate analysis. Only BMI was a sig-
Table 2: Operative and Perioperative Details
Group 1 Group 2 p value
Type of surgery
CABG 41 (100.0%) 40 (100.0%)
On Pump 41 (100.0%) 40 (100.0%)
Number of ITA grafts used
One 41 (100.0%) 0 (0.0%) 0.000
Two 0 (0.0%) 40 (100.0%)
Number of distal anastomosis 3.3 ± 0.9 3.2 ± 6.7 0.810
With vein grafts 1.9 ± 0.8 1.0 ± 0.5 0.000
With arterial grafts 1.3 ± 0.5 2.3 ± 0.5 0.000
Duration of operation (min) 245.8 ± 40.0 272.8 ± 44.2 0.005
CPB time (min) 97.0 ± 21.6 110.8 ± 21.1 0.005
Cross-clamp time (min) 66.7 ± 18.6 87.0 ± 18.2 0.000
Re-exploration for bleeding 0 (0.0%) 2 (5.0%) 0.241
Postoperative bleeding (ml) 513.9 ± 239.6 836.5 ± 1025.1 0.059
Transfused patients 14 (34.1%) 11 (27.5%) 0.632
Red blood cell units 0.9 ± 1.4 0.8 ± 2.0 0.893
Postoperative intubation (hours) 7.8 ± 6.7 7.0 ± 5.9 0.676
Intensive Care Unit stay (days) 2.4 ± 4.1 1.8 ± 0.7 0.311
Table 3: Details of sternal SSIs and clinical outcomes.
Group 1 Group 2 p value
Organ/space sternal SSIs 0 (0.0%) 0 (0.0%)
Superficial sternal SSIs 2 (4.9%) 3 (7.5%) 0.675
Staphylococcus Aureus 12
Staphylococcus Epidermidis 11
Time from surgery to recognized infection (days) 18.5 ± 2.1 7.3 ± 3.0
Duration of infection until sterilization (days) 14.0 ± 4.2 13.3 ± 3.7
Infection relapse rate 0 (0.0%) 0 (0.0%)
Total hospital length of stay (days) 15.5 ± 3.5 19.0 ± 7.0Journal of Cardiothoracic Surgery 2008, 3:35 http://www.cardiothoracicsurgery.org/content/3/1/35
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nificant predictor of SSI using multivariate stepwise logis-
tic regression analysis (Odds Ratio: 1.34;
95%Conficdence Interval: 1.02–1.83; p value: 0.04). In
the model, the use of BITA was not an independent pre-
dictor of SSI.
Discussion
The use of bilateral ITAs has been associated with better
long-tern outcomes than single LITA graft. It improves
survival and reduces the need for repeat revascularization
[9,10], even in diabetic patients. Moreover, RITA graft has
been reported to have a long-term patency rate similar to
LITA graft [11]. Nevertheless, the perception of an
increased risk of SSI has limited the BITA harvesting in
patients with diabetes [12]. This prospective non-rand-
omized study was undertaken to understand if bilateral
pedicled ITAs in diabetics increase early risks despite the
potential later benefit.
The two groups were similar and comparable for all pre-
operative, operative and postoperative parameters but
age, previous myocardial infarction, EF and EURO-
SCORE. These differences reflect the indications to per-
form BITA grafting in our Institution. The use of BITA
grafts significantly prolongs the total and cross-clamping
time and it should be avoided in patients with higher
operative risks in which aortic cross-clamping time should
be shortened. Older patients are at higher operative risk,
as well as patients with preoperative heart failure [21,22].
By its definition, the higher EUROSCORE of Group 1 con-
firms these data [13-15]. Nonetheless, these parameters
are not considered risk factors for SSI and the should not
alter the homogeneity of the groups [23].
The main outcome of this study is the similar rate of SSI
of the 2 groups. The use of BITAs is considered by many
Authors a significant risk factor for sternal dehiscence and
mediastinal wound infection, as it leads to severe acute
impairment of sternal blood supply. Single ITA harvesting
leads to a 90% loss of hemisternum blood supply and
bilateral ITAs mobilization can devascularize the entire
sternum and compromise the healing of the sternal
wound [5-7], especially in diabetic patients that are at
higher risk of SSI. Diabetes is a well known risk factor for
postoperative sternal SSI, but this study did not find sig-
nificant differences between patients with single or bilat-
eral ITAs harvesting. Even the multivariate analysis
confirms that only BMI is an independent risk factor for
SSI.
Pedicled bilateral ITA harvesting is traditionally consid-
ered hazardous in diabetics and many prefer skeletonized
ITA mobilization, because skeletonized ITAs are associ-
ated with a higher residual sternal blood supply than that
dissected as a pedicle [24]. Recent articles report that skel-
etonization of both ITAs decreases the risk of sternal infec-
tion in diabetic patients [25] and shows good short as well
as long term cardiac outcome [26]. ITA skeletonization is
technically more demanding and more time consuming
than pedicled ITA harvesting; it has a surgical learning
curve and there is no current data on long term patency
rates [27]. Our data show that bilateral pedicled ITAs can
be used in diabetic patients without increased morbidity
and mortality. These results were achieved through vari-
ous factors, including meticulous pedicled ITA harvesting,
placement of 2 adjunctive drain tubes to keep the sternal
wound dry in the postoperative period, careful wound
closure, especially in obese patients and continuous and
aggressive blood glucose monitoring in the postoperative
period.
Our postoperative infections were only superficial and
complete healing and primary wound closure were always
achieved; no sternal dehiscence and no deep sternum
infection were observed in our cases.
Limitations of this study
This study is prospective in nature but patients were not
randomized. Outcomes have to be confirmed by rand-
omized controlled trials in order to unmask eventual con-
founding factors. Moreover the dimension of the 2 groups
is limited, as shown by the wide confidence interval.
Conclusion
CABG with bilateral pedicled ITAs grafting could be per-
formed safely even in diabetics with poor preoperative
glycaemic control. However, in order to limit SSIs, these
patients need a strict post-operative blood glucose con-
trol.
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